Atlas Trials

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer

Clinical trial NCT00123747 · COMPLETED

Trial details

NCT number
NCT00123747
Sponsor
AHS Cancer Control Alberta
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Neoplasms
Start date
2005-08-01
Primary completion
2008-10-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.